ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 201290 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 201290; 2) Community: the network communities that were significantly associated with the response to NSC 201290; 3) Molecule: the relationships between components within communities and NSC 201290; 4) MDR: the compounds that were significantly associated with the NSC 201290.

NSC Compound Enrichment Correlation
NSC 173516 1,3,5-Triazine-2,4-diamine, 1-[4-fluoro-3-(trifluoromethyl)phenyl]-1,6-dihydro-6,6-dimethyl-, monohydrochloride 0.000574000735425498 0.45558411
NSC 382032 Null 0.00061365589440402 0.45132862
NSC 672140 Null 0.000839001373926613 0.21856485
NSC 686554 9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-(2-pyridinyl)- 0.000839001373926613 0.38376193
NSC 726217 Combretastatin A4-analogue 0.000839001373926613 0.38118191
NSC 752506 5-nitro-N-((pyridin-3-yl)methyl)furan-2-carboxamide 0.000839001373926613 -0.0061949155
NSC 376266 1-Piperazinethiocarboxylic acid, 4-(2-propynyl)- 2-[1-(2-pyridinyl)ethylidene]hydrazide 0.000864859564133839 0.34249657
NSC 710342 4H-1-Benzopyran-4-one, 2-(2,4-dihydroxyophenyl)-5,7-dihydroxy-3,6,8-tris(3-methyl-2-butenyl)- (9CI) 0.000864859564133839 0.55867273
NSC 710525 Null 0.000864859564133839 0.3112592
NSC 706999 Cystothiazole A 0.00098268217727352 0.27521289
Total:94  Current:3    [First] [Prev] [Next] [Last]